AU2001275244A1 - Starter kit for low dose oral contraceptives - Google Patents
Starter kit for low dose oral contraceptivesInfo
- Publication number
- AU2001275244A1 AU2001275244A1 AU2001275244A AU7524401A AU2001275244A1 AU 2001275244 A1 AU2001275244 A1 AU 2001275244A1 AU 2001275244 A AU2001275244 A AU 2001275244A AU 7524401 A AU7524401 A AU 7524401A AU 2001275244 A1 AU2001275244 A1 AU 2001275244A1
- Authority
- AU
- Australia
- Prior art keywords
- low dose
- oral contraceptives
- dose oral
- starter kit
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
The present invention provides a contraceptive kit which helps to overcome or ameliorate the problem of breakthrough bleeding and spotting associated with lowest dose (15-20 ug EE) estrogen contraceptives.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21031000P | 2000-06-08 | 2000-06-08 | |
US60/210,310 | 2000-06-08 | ||
PCT/US2001/018142 WO2001093848A2 (en) | 2000-06-08 | 2001-06-05 | Starter kit for low dose oral contraceptives |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001275244A1 true AU2001275244A1 (en) | 2001-12-17 |
Family
ID=22782382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001275244A Abandoned AU2001275244A1 (en) | 2000-06-08 | 2001-06-05 | Starter kit for low dose oral contraceptives |
Country Status (14)
Country | Link |
---|---|
US (1) | US7297688B2 (en) |
EP (1) | EP1286666B1 (en) |
JP (1) | JP2003535127A (en) |
CN (1) | CN1313095C (en) |
AT (1) | ATE286726T1 (en) |
AU (1) | AU2001275244A1 (en) |
BR (1) | BR0111509A (en) |
CA (1) | CA2410993A1 (en) |
DE (1) | DE60108377T2 (en) |
ES (1) | ES2236243T3 (en) |
MX (1) | MXPA02012108A (en) |
PT (1) | PT1286666E (en) |
SI (1) | SI1286666T1 (en) |
WO (1) | WO2001093848A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060281723A1 (en) * | 1999-04-16 | 2006-12-14 | Kafrissen Michael E | Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
WO2004098517A2 (en) * | 2003-05-02 | 2004-11-18 | Duramed Pharmaceuticals, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
EP1648382A4 (en) | 2003-07-16 | 2009-09-16 | Duramed Pharmaceuticals Inc | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
DE102004026671A1 (en) * | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Dosage form for hormonal contraception |
EP1814556A2 (en) * | 2004-10-07 | 2007-08-08 | Duramed Pharmaceuticals Inc. | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
US7704984B2 (en) * | 2005-04-22 | 2010-04-27 | Warner Chilcott Company, Llc | Extended estrogen dosing contraceptive regimen |
DE102005034498A1 (en) * | 2005-07-20 | 2007-01-25 | Grünenthal GmbH | Oral contraception with Trimegeston |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4530839A (en) | 1983-09-26 | 1985-07-23 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
IE62665B1 (en) | 1990-12-17 | 1995-02-22 | Akzo Nv | Contraceptive regimen |
US5552394A (en) * | 1994-07-22 | 1996-09-03 | The Medical College Of Hampton Roads | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
DE19525017A1 (en) | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmaceutical combination preparation, kit and method for hormonal contraception |
DE19540253C2 (en) | 1995-10-28 | 1998-06-04 | Jenapharm Gmbh | Multi-phase preparation for contraception based on natural estrogens |
WO1997041870A1 (en) | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
DK0917466T3 (en) | 1996-07-26 | 2004-12-20 | Wyeth Corp | Oral contraceptive |
US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
DE19739916C2 (en) | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Use of a combination of a progestogen and an estrogen for the continuous inhibition of ovulation and possibly simultaneous treatment and / or prophylaxis of tumors of the mammary glands |
EP2002839A1 (en) | 1998-04-17 | 2008-12-17 | Ortho McNeil Pharmaceutical, Inc. | Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
-
2001
- 2001-06-01 US US09/872,250 patent/US7297688B2/en not_active Expired - Fee Related
- 2001-06-05 CA CA002410993A patent/CA2410993A1/en not_active Abandoned
- 2001-06-05 SI SI200130292T patent/SI1286666T1/en unknown
- 2001-06-05 AU AU2001275244A patent/AU2001275244A1/en not_active Abandoned
- 2001-06-05 PT PT01941933T patent/PT1286666E/en unknown
- 2001-06-05 ES ES01941933T patent/ES2236243T3/en not_active Expired - Lifetime
- 2001-06-05 EP EP01941933A patent/EP1286666B1/en not_active Expired - Lifetime
- 2001-06-05 BR BR0111509-0A patent/BR0111509A/en not_active Application Discontinuation
- 2001-06-05 WO PCT/US2001/018142 patent/WO2001093848A2/en active IP Right Grant
- 2001-06-05 DE DE60108377T patent/DE60108377T2/en not_active Expired - Fee Related
- 2001-06-05 AT AT01941933T patent/ATE286726T1/en not_active IP Right Cessation
- 2001-06-05 CN CNB018109020A patent/CN1313095C/en not_active Expired - Fee Related
- 2001-06-05 MX MXPA02012108A patent/MXPA02012108A/en active IP Right Grant
- 2001-06-05 JP JP2002501421A patent/JP2003535127A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2001093848A2 (en) | 2001-12-13 |
DE60108377D1 (en) | 2005-02-17 |
US7297688B2 (en) | 2007-11-20 |
MXPA02012108A (en) | 2003-04-25 |
PT1286666E (en) | 2005-05-31 |
SI1286666T1 (en) | 2005-06-30 |
EP1286666B1 (en) | 2005-01-12 |
BR0111509A (en) | 2003-07-08 |
CA2410993A1 (en) | 2001-12-13 |
JP2003535127A (en) | 2003-11-25 |
ATE286726T1 (en) | 2005-01-15 |
CN1313095C (en) | 2007-05-02 |
EP1286666A2 (en) | 2003-03-05 |
DE60108377T2 (en) | 2006-04-06 |
US20020010167A1 (en) | 2002-01-24 |
CN1436081A (en) | 2003-08-13 |
WO2001093848A3 (en) | 2003-01-09 |
ES2236243T3 (en) | 2005-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL148211A0 (en) | Selecting the delivery mechanism of an urgent message | |
HK1154485A1 (en) | Oral contraceptives to prevent pregnancy | |
WO2002040495A3 (en) | Improved sucralose composition and process for the crystallization thereof | |
MXPA02012897A (en) | Combinations of bisphosphonates, estrogenic agents and optionally estrogens. | |
GEP20063882B (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
GB0114825D0 (en) | Photoresist composition | |
AU2002224198A1 (en) | Fragrance composition comprising cyclohexadecanone | |
MXPA02012896A (en) | Combinations of statins, estrogenic agents and optionally estrogens. | |
AU2001275244A1 (en) | Starter kit for low dose oral contraceptives | |
CA2415197A1 (en) | Cast wheel rim | |
WO2001078682A3 (en) | Sustained release drug compositions | |
GB0007760D0 (en) | Composition | |
EP1275394A3 (en) | Ultra low dose oral contraceptives with sustained efficacy that induces amenorrhea | |
AU2002218278A1 (en) | Water-selective cementing composition | |
GB0013350D0 (en) | End of message markers | |
AU1142502A (en) | Novel crystalline forms of a factor xa inhibitor | |
AU2001252770A1 (en) | Electron-beam lithography | |
AU2002210683A1 (en) | Identification of hla-dr restricted hcv epitopes | |
ZA200300417B (en) | 16alpha-methyl or ethyl substituted estrogens. | |
DE60212130D1 (en) | Carvedilolpolymorph | |
AU2001268689A1 (en) | Alpha-arylated cinnamic esters and 1,4-bis(alpha-carboxyl-beta-styryl)benzene esters as uv-blocking agents | |
WO2001071346A3 (en) | Binding compounds for cc chemokine receptor 5 and methods for identifying them | |
ZA200309578B (en) | Male contraceptives. | |
ZA200001843B (en) | Preparation of standard gas mixtures. | |
WO2005046566A3 (en) | Stable gabapentin containing composition |